Related Experiment Video
Updated: Nov 19, 2025

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
Marzia Di Donato1, Alice Zamagni2, Giovanni Galasso1
1Department of Precision Medicine, University of Campania 'L. Vanvitelli'- Via L. De Crecchio, 7- 80138, Naples, Italy.
Abstract:
Prostate cancer represents the major cause of cancer-related death in men and patients frequently develop drug-resistance and metastatic disease. Most studies focus on hormone-resistance mechanisms related to androgen receptor mutations or to the acquired property of prostate cancer cells to over-activate signaling pathways. Tumor microenvironment plays a critical role in prostate cancer progression. However, the mechanism involving androgen/androgen receptor signaling in cancer associated fibroblasts and consequences for prostate cancer progression still remains elusive. We now report that prostate cancer associated fibroblasts express a transcriptional-incompetent androgen receptor. Upon androgen challenging, the receptor co-localizes with the scaffold protein filamin A in the extra-nuclear compartment of fibroblasts, thus mediating their migration and invasiveness. Cancer-associated fibroblasts move towards epithelial prostate cancer cells in 2D and 3D cultures, thereby inducing an increase of the prostate cancer organoid size. Androgen enhances both these effects through androgen receptor/filamin A complex assembly in cancer-associated fibroblasts. An androgen receptor-derived stapled peptide, which disrupts the androgen receptor/filamin A complex assembly, abolishes the androgen-dependent migration and invasiveness of cancer associated fibroblasts. Notably, the peptide impairs the androgen-induced invasiveness of CAFs in 2D models and reduces the overall tumor area in androgen-treated 3D co-culture. The androgen receptor in association with β1 integrin and membrane type-matrix metalloproteinase 1 activates a protease cascade triggering extracellular matrix remodeling. The peptide also impairs the androgen activation of this cascade. This study offers a potential new marker, the androgen receptor/filamin A complex, and a new therapeutic approach targeting intracellular pathways activated by the androgen/androgen receptor axis in prostate cancer-associated fibroblasts. Such a strategy, alone or in combination with conventional therapies, may allow a more efficient treatment of prostate cancer.
Insights
Prostate cancer fibroblasts migrate and invade when exposed to androgens, driven by a non-functional androgen receptor interacting with filamin A. A peptide disrupting this complex inhibits prostate cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Prostate cancer is a leading cause of cancer death in men, often becoming drug-resistant and metastatic.
- Current research often focuses on androgen receptor mutations or signaling pathway over-activation in cancer cells.
- The role of androgen/androgen receptor signaling in cancer-associated fibroblasts (CAFs) and its impact on prostate cancer progression remain unclear.
Purpose of the Study:
- To investigate the mechanism of androgen/androgen receptor signaling in prostate cancer-associated fibroblasts.
- To determine the consequences of this signaling on prostate cancer progression and tumor microenvironment.
- To identify potential therapeutic targets within this pathway.
Main Methods:
- Analysis of androgen receptor (AR) expression and localization in prostate cancer-associated fibroblasts (CAFs).
- Investigation of AR co-localization with filamin A (FLNA) upon androgen stimulation.
- Use of 2D and 3D co-culture models with prostate cancer organoids and CAFs.
- Assessment of CAF migration, invasiveness, and impact on organoid growth.
- Application of an AR-derived stapled peptide to disrupt the AR/FLNA complex.
- Evaluation of extracellular matrix remodeling and protease cascade activation.
Main Results:
- Prostate cancer-associated fibroblasts express a transcriptionally incompetent AR that co-localizes with FLNA in the extra-nuclear compartment upon androgen challenge.
- Androgen stimulation enhances CAF migration and invasiveness, leading to increased prostate cancer organoid size.
- An AR-derived stapled peptide disrupts the AR/FLNA complex, inhibiting androgen-dependent CAF migration and invasiveness.
- The peptide reduces overall tumor area in 3D co-cultures and impairs the androgen-induced protease cascade involving β1 integrin and MMP1.
- The AR/FLNA complex is identified as a potential marker, and its disruption a therapeutic strategy.
Conclusions:
- Androgen signaling through a non-canonical AR/FLNA complex in CAFs promotes prostate cancer progression.
- Disruption of the AR/FLNA complex using a stapled peptide represents a novel therapeutic strategy.
- Targeting this pathway in CAFs offers a potential approach to improve prostate cancer treatment, alone or in combination with existing therapies.
Related Concept Videos
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions
Some...

